Crossmark

A Monoclonal Antibody Against the Oligomeric Form of the Large C-Terminal Fragment (Met225–Ile412) of Bacillus cereus Hemolysin II is Capable of Strain-Specific Inhibition of the Hemolytic Activity

Crossref DOI link: https://doi.org/10.1134/S1068162024605949

Published Online: 2025-04-06

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vetrova, O. S.

Rudenko, N. V.

Zamyatina, A. V.

Nagel, A. S.

Andreeva-Kovalevskaya, Zh. I.

Siunov, A. V.

Brovko, F. A.

Solonin, A. S.

Karatovskaya, A. P.
License Information

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2025-04-01
More Information

Article History

Received: 1 October 2024

Revised: 15 October 2024

Accepted: 16 October 2024

First Online: 6 April 2025

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: All applicable international and institutional guidelines for the care and use of animals were followed. Animal studies were approved by the Committee for the Control of the Care and Use of Laboratory Animals of the IBC RAS (protocol no. 998/24 of September 21, 2024).

: This article contains no description of any research involving humans as research subjects. No conflicts of interest was declared by the authors.

Document is current

Any future updates will be listed below